CHI3L2 and myeloid sarcoma: A recent study used quantitative proteomics methods to analyze differences in CSF proteins between control and RRMS patients, chitinase 3-like proteins 1 (CHI3L1) and 2 (CHI3L2) are highly expressed in the brains of patients with MS (Hinsinger et al., 2015).